Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with dextrocardia, tetralogy of Fallot, and conduction disease

Scott R Ceresnak; Kara S Motonaga; Ian S Rogers; Mohan N Viswanathan

doi:10.1016/j.hrcr.2015.02.001

Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with dextrocardia, tetralogy of Fallot, and conduction disease

HeartRhythm Case Rep. 2015 Jun 12;1(4):186-189. doi: 10.1016/j.hrcr.2015.02.001. eCollection 2015 Jul.

Authors

Scott R Ceresnak¹, Kara S Motonaga¹, Ian S Rogers², Mohan N Viswanathan³

Affiliations

¹ Division of Pediatric Cardiology, Pediatric Electrophysiology, Department of Pediatrics, Stanford University, Palo Alto, California.
² Division of Cardiology, Department of Internal Medicine and Pediatrics, Stanford University, Palo Alto, California.
³ Division of Cardiology-Electrophysiology, Department of Internal Medicine, Stanford University, Palo Alto, California.

No abstract available

Keywords: ATP, antitachycardia pacing; Congenital heart disease; Dextrocardia; ICD, implantable cardioverter-defibrillator; Pediatrics; RV, right ventricle; RVOT, right ventricular outflow tract; S-ICD, subcutaneous implantable cardioverter-defibrillator; Subcutaneous implantable cardioverter-defibrillator; Tetralogy of Fallot; VF, ventricular fibrillation.

Publication types

Case Reports